Uni-Bio Science Group Limited (SEHK: 690)
Health Care · Biotechnology · HK
HK$0.07
-4.29% today · -47.7% 1Y
Uni-Bio Science Group Limited (SEHK: 690) operates in the Biotechnology industry within the Health Care sector. The company is valued at $50.98M.
Over the last twelve months the share price has lost 47.7%, trading between 0.05 and 0.14.
Tweenvest scores Uni-Bio Science Group Limited across four factors: quality 76/100, value 36/100, growth 68/100, dividend 71/100. Its strongest factor is quality.
690 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $50.98M
- Revenue (TTM)
- $70.10M
- P/E
- 8.27
- EPS
- 0.01
- Dividend yield
- 4.67%
- Beta (5Y)
- -0.15
- 52-week high
- HK$0.14
- 52-week low
- HK$0.05
- Avg volume (3M)
- —
- Shares outstanding
- 5.97B
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| RenovoRx, Inc.NasdaqCM: RNXT | $51.45M | $1.14 | -10.94% |
| Synbio Tech Inc.TPEX: 1295 | $51.37M | NT$48.35 | -3.49% |
| Prestige BioPharma LimitedKOSE: A950210 | $51.30M | ₩5,690.00 | -4.53% |
| Nano Holdings, Inc.TSE: 4571 | $51.13M | ¥89.00 | +12.66% |
| Rein Therapeutics Inc.NasdaqCM: RNTX | $50.92M | $0.59 | -25.65% |
| Cellid, Co., Ltd.KOSDAQ: A299660 | $50.90M | ₩2,300.00 | -8.18% |
| FluoGuide A/SOM: FLUO | $50.52M | Skr30.60 | -3.47% |
| Naturalendo Tech Co., Ltd.KOSDAQ: A168330 | $50.32M | ₩2,125.00 | -11.09% |
Figures last refreshed Oct 18, 2026.